About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Sodium Zirconium Cyclosilicate
- Company
- AstraZeneca
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 5 recruiting
Efficacy results: Not yet reported
5 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026
Find a Clinical Trial Near Me
See recruiting studies for Sodium Zirconium Cyclosilicate and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT03813407
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Not yet reported AstraZeneca 140 participants Est. completion 2030-02-21 70 sites Stand-aloneOther conditions: HyperkalaemiaView official trial listing → -
Recruiting NCT NCT06578078
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
Not yet reported Fundación para la Investigación del Hospital Clínico de Valencia 94 participants Est. completion 2026-12-30 6 sites Stand-aloneHeart failureChronic kidney diseaseView official trial listing → -
Recruiting NCT NCT06578533
Keeping RAASi Treatment With Optimal Potassium Control
Not yet reported Fundación para la Investigación del Hospital Clínico de Valencia 78 participants Est. completion 2027-07-30 5 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Recruiting NCT NCT07029503
Swedish Cardiac And Renal Failure Study-1
Not yet reported Karolinska Institutet 40 participants Est. completion 2027-10 1 site Stand-aloneHeart failureChronic kidney diseaseView official trial listing → -
Recruiting NCT NCT07944378
A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia
Not yet reported AstraZeneca 120 participants Est. completion 2027-10-30 4 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT02088073
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
Not yet reported ZS Pharma, Inc. 258 participants Est. completion 2015-01-31 46 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT02107092
Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
Not yet reported ZS Pharma, Inc. 123 participants Est. completion 2015-08-31 49 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT02163499
Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
Not yet reported ZS Pharma, Inc. 751 participants Est. completion 2016-11-30 50 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT02875834
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia
Not yet reported AstraZeneca 267 participants Est. completion 2018-02-14 45 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT03127644
ZS Ph2/3 Dose-response Study in Japan
Not yet reported, Not yet reported AstraZeneca 103 participants Est. completion 2018-02-23 25 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT03172702
Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
Not yet reported AstraZeneca 150 participants Est. completion 2019-07-06 42 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT03283267
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
Not yet reported AstraZeneca 22 participants Est. completion 2017-11-23 1 site Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT03303521
A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.
Not yet reported AstraZeneca 196 participants Est. completion 2018-11-07 53 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT03337477
A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8
Not yet reported AstraZeneca 70 participants Est. completion 2018-12-21 25 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT03528681
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
Not yet reported AstraZeneca 270 participants Est. completion 2022-09-15 66 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Terminated NCT NCT03532009
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Not yet reported AstraZeneca 182 participants Est. completion 2020-05-22 76 sites Stand-aloneHeart failureView official trial listing → -
Status unknown NCT NCT04063930
The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia
Not yet reported Steno Diabetes Center Copenhagen 20 participants Est. completion 2021-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04207203
Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study
Not yet reported Karolinska Institutet 26 participants Est. completion 2023-05-10 1 siteChronic kidney disease Other conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT04217590
Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects
Not yet reported AstraZeneca 134 participants Est. completion 2022-01-03 36 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT04566653
Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia
AstraZeneca 147 participants Est. completion 2022-01-12 18 sitesHeart failureChronic kidney diseaseView official trial listing → -
Terminated NCT NCT04585542
Comparison of Potassium Binders in the ER
Not yet reported University of California, Irvine 37 participants Est. completion 2025-01-31 1 site Stand-aloneOther conditions: Acute Hyperkalemia, Oral Potassium BindersView official trial listing → -
Completed NCT NCT04676646
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
Not yet reported AstraZeneca 366 participants Est. completion 2024-07-15 89 sites Stand-aloneHeart failure Other conditions: HyperkalaemiaView official trial listing → -
Terminated NCT NCT04727528
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
Not yet reported AstraZeneca 39 participants Est. completion 2022-09-14 30 sites Stand-aloneChronic kidney disease Other conditions: Hyperkalaemia, Metabolic AcidosisView official trial listing → -
Status unknown NCT NCT04727840
Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)
Not yet reported Brigham and Women's Hospital 20 participants Est. completion 2022-01-15 1 siteChronic kidney disease Other conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT04788641
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
Not yet reported AstraZeneca 62 participants Est. completion 2021-09-16 1 site Stand-aloneOther conditions: HyperkalaemiaView official trial listing → -
Active, not recruiting NCT NCT04789239
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
Not yet reported Michael Fu 110 participants Est. completion 2025-12-31 2 sites Stand-aloneHeart failure Other conditions: HyperkalemiaView official trial listing → -
Terminated NCT NCT04847232
Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
Not yet reported AstraZeneca 2690 participants Est. completion 2024-03-07 340 sites Stand-aloneOther conditions: HyperkalemiaView official trial listing → -
Terminated NCT NCT04983979
The ORTIZ Study: Optimising RASi Therapy With SZC
Not yet reported Barts & The London NHS Trust 18 participants Est. completion 2023-05-16 1 site Stand-aloneChronic kidney diseaseType 2 diabetes Other conditions: HyperkalemiaView official trial listing → -
Terminated NCT NCT04997161
Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia
Not yet reported AstraZeneca 3 participants Est. completion 2021-11-17 1 site Stand-aloneOther conditions: HyperkalaemiaView official trial listing → -
Completed NCT NCT05004363
Lokelma for RAAS Maximisation in CKD & Heart Failure.
Not yet reported St George's, University of London 112 participants Est. completion 2024-07-01 1 siteChronic kidney diseaseHeart failure Other conditions: Hyperkalemia, ACE Inhibitor Induced Hyperkalaemia, Mineralocorticoid Resistant HyperkalemiaView official trial listing → -
Terminated NCT NCT05056727
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
Not yet reported AstraZeneca 1112 participants Est. completion 2024-02-07 276 sites Stand-aloneOther conditions: Renal Insufficiency, Chronic, HyperkalemiaView official trial listing → -
Completed NCT NCT05271266
A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China
AstraZeneca 1000 participants Est. completion 2023-12-06 27 sitesOther conditions: HyperkalaemiaView official trial listing → -
Completed NCT NCT05347693
Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
Not yet reported AstraZeneca 186 participants Est. completion 2024-12-10 28 sites Stand-aloneChronic kidney disease Other conditions: HyperkalaemiaView official trial listing → -
Completed NCT NCT05382988
Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy
Not yet reported Guangdong Provincial People's Hospital 62 participants Est. completion 2021-12 Stand-aloneOther conditions: Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, SecondaryView official trial listing → -
Completed NCT NCT05535920
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
Not yet reported NephroNet, Inc. 88 participants Est. completion 2024-04-01 5 sitesOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT06029179
SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients
Not yet reported Alexandria University 120 participants Est. completion 2024-12-15 1 siteOther conditions: HyperkalemiaView official trial listing → -
Completed NCT NCT06185660
A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
AstraZeneca 125 participants Est. completion 2025-01-03 10 sitesOther conditions: HyperkalaemiaView official trial listing → -
Status unknown NCT NCT06365684
Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4
Not yet reported Leiden University Medical Center 16 participants Est. completion 2025-05-01 1 site Stand-aloneChronic kidney disease Other conditions: Hyperkalemia, Diet Modification, Sodium Zirconium CyclosilicateView official trial listing → -
Completed NCT NCT06635499
VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spain
AstraZeneca 232 participants Est. completion 2025-05-20 14 sitesOther conditions: HyperkalaemiaView official trial listing → -
Not yet recruiting NCT NCT06736184
the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
Not yet reported Qianfoshan Hospital 100 participants Est. completion 2026-12-31 Stand-aloneChronic kidney disease Other conditions: Hypokalemia, Hyperkalemia, Myocardial InjuryView official trial listing → -
Not yet recruiting NCT NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)
Not yet reported Sahlgrenska University Hospital 110 participants Est. completion 2030-06-30Heart failureView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Sodium Zirconium Cyclosilicate, LOKELMA
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
